After finishing at $5.81 in the prior trading day, Prime Medicine Inc (NASDAQ: PRME) closed at $5.73, down -1.38%. On the day, 509055 shares were traded.
Ratios:
Our goal is to gain a better understanding of PRME by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.03.
On April 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $12.
Stifel Downgraded its Buy to Hold on January 16, 2024, whereas the target price for the stock was revised from $18 to $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 15 ’24 when ARCH Venture Partners XII, LLC bought 3,200,000 shares for $6.25 per share. The transaction valued at 20,000,000 led to the insider holds 3,200,000 shares of the business.
ARCH Venture Partners X, LLC bought 3,200,000 shares of PRME for $20,000,000 on Feb 15 ’24. The 10% Owner now owns 3,200,000 shares after completing the transaction at $6.25 per share. On Feb 15 ’24, another insider, NELSEN ROBERT, who serves as the Director of the company, bought 3,200,000 shares for $6.25 each. As a result, the insider paid 20,000,000 and bolstered with 3,200,000 shares of the company.
Stock Price History:
Over the past 52 weeks, PRME has reached a high of $17.20, while it has fallen to a 52-week low of $5.47.
Shares Statistics:
A total of 97.38M shares are outstanding, with a floating share count of 49.77M. Insiders hold about 58.50% of the company’s shares, while institutions hold 22.37% stake in the company.
Earnings Estimates
Its stock is currently analyzed by PRME different market analysts. The consensus estimate for the next quarter is $5.73, with high estimates of $3.72 and low estimates of $7.25.
Analysts are recommending an EPS of between $Healthcare and $Basic Materials for the fiscal current year, implying an average EPS of $Healthcare.
